local
Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing
By By Colossal Biosciences Inc. at Denton Record-Chronicle
· June 30, 2026
· 1 min read
The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer that has driven 80% population declines across Tasmania
Why this matters in Denton News
While the partnership between Colossal Foundation and the University of Tasmania may seem distant from Denton , the collaboration's focus on conservation biotechnology has implications for local wildlife preservation efforts. The use of gene editing and vaccines to combat disease in Tasmanian devils could potentially inform strategies for managing diseases affecting native Texas species. Denton County is home to a diverse range of wildlife, and the county's natural areas and wildlife refuges may benefit from innovative approaches to disease management. As the city of Denton continues to grow and develop, balancing urban expansion with wildlife conservation will become increasingly important. The success of Colossal's biotechnology platform in saving the Tasmanian devil could have a ripple effect, inspiring new approaches to conservation in North Texas and beyond. Local conservation groups and wildlife experts may be watching this partnership closely, looking for lessons that can be applied to protect Denton County's own unique wildlife.
About this story
Original reporting by Denton Record-Chronicle . Denton News surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit Denton Record-Chronicle . Have a tip or correction? Contact our newsroom .
Category: local ·
Published: June 30, 2026 ·
Source: Denton Record-Chronicle ·
Reading time: 1 min
Get more Denton News stories like this
Free weekly briefing covering local and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer that has driven 80% population declines across Tasmania
When was this published? This article was first published on June 30, 2026 by Denton Record-Chronicle and curated for Denton News readers.
Who reported this story? This story was reported by By Colossal Biosciences Inc. at Denton Record-Chronicle. To learn more about how Denton News selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from Denton News, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter